ISOMORPHIC LABS

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ISOMORPHIC LABS wurde als Wortmarke am 21.02.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 19. Juli 2023

Markenform Wortmarke
Aktenzeichen 1683865
Registernummer UK00003718449
Länder Kanada China Europäische Gemeinschaft Indien
Basismarke GB Nr. UK00003718449, 28. Januar 2022
Anmeldedatum 21. Februar 2022
Ablaufdatum 21. Februar 2032

Markeninhaber

100 New Bridge Street
LONDON EC4V 6JA
GB

Markenvertreter

4 Rubislaw Place ABERDEEN AB10 1XN GB

Waren und Dienstleistungen

09 Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; recorded and downloadable media, computer software, blank digital or analogue recording and storage media; mechanisms for coin-operated apparatus; cash registers, calculating devices; computers and computer peripheral devices; diving suits, divers' masks, ear plugs for divers, nose clips for divers and swimmers, gloves for divers, breathing apparatus for underwater swimming; fire-extinguishing apparatus; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development
42 Scientific and technological services and research and design relating thereto; industrial analysis and industrial research services; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development (in the opinion of the International Bureau these terms are too vague - Rule 13.2.b) of the Common Regulations); software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software platforms for artificial intelligence, machine earning, deep learning, and reinforcement learning; development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
28. Februar 2023 2023/9 Gaz CN Ablehnung
23. Februar 2023 2023/9 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
17. Oktober 2022 2022/42 Gaz IN Ablehnung
21. September 2022 2022/39 Gaz EM Ablehnung
21. Februar 2022 2022/35 Gaz GB Eintragung

ID: 141683865